|
1
|
Gao X, McDonald JT, Hlatky L and Enderling
H: Acute and fractionated irradiation differentially modulate
glioma stem cell division kinetics. Cancer Res. 73:1481–1490. 2013.
View Article : Google Scholar
|
|
2
|
Kim JJ and Tannock IF: Repopulation of
cancer cells during therapy: an important cause of treatment
failure. Nat Rev Cancer. 5:516–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Idema AJ, Hoffmann AL, Boogaarts HD, et
al: 3′-Deoxy-3′-18F-fluorothymidine PET-derived proliferative
volume predicts overall survival in high-grade glioma patients. J
Nucl Med. 53:1904–1910. 2012.
|
|
4
|
Herrmann K, Buck AK, Schuster T, et al: A
pilot study to evaluate 3′-deoxy-3′-18F-fluorothymidine pet for
initial and early response imaging in mantle cell lymphoma. J Nucl
Med. 52:1898–1902. 2011.
|
|
5
|
Maciejewski B and Majewski S: Dose
fractionation and tumour repopulation in radiotherapy for bladder
cancer. Radiother Oncol. 21:163–170. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Withers HR, Peters LJ, Taylor JM, et al:
Local control of carcinoma of the tonsil by radiation therapy: an
analysis of patterns of fractionation in nine institutions. Int J
Radiat Oncol Biol Phys. 33:549–562. 1995. View Article : Google Scholar
|
|
7
|
Petereit DG, Sarkaria JN, Chappell R, et
al: The adverse effect of treatment prolongation in cervical
carcinoma. Int J Radiat Oncol Biol Phys. 32:1301–1307. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Withers HR, Taylor JM and Maciejewski B:
The hazard of accelerated tumor clonogen repopulation during
radiotherapy. Acta Oncol. 27:131–146. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baumann M, Herrmann T, Koch R, et al;
CHARTWEL-Bronchus studygroup. Final results of the randomized phase
III CHARTWEL-trial (ARO 97-1) comparing
hyperfractionated-accelerated versus conventionally fractionated
radiotherapy in non-small cell lung cancer (NSCLC). Radiother
Oncol. 100:76–85. 2011. View Article : Google Scholar
|
|
10
|
Wang JH, Lu XJ, Zhou J and Wang F: A
randomized controlled trial of conventional fraction and late
course accelerated hyperfraction three-dimensional conformal
radiotherapy for esophageal cancer. Cell Biochem Biophys.
62:107–112. 2012. View Article : Google Scholar
|
|
11
|
Nakamura K, Kodaira T, Shikama N, et al:
Accelerated fractionation versus conventional fractionation
radiation therapy for glottic cancer of T1-2N0M0 Phase III study:
Japan Clinical Oncology Group study (JCOG 0701). Jpn J Clin Oncol.
38:387–389. 2008. View Article : Google Scholar
|
|
12
|
Gao M, Mayr NA, Huang Z, Zhang H and Wang
JZ: When tumor repopulation starts? The onset time of prostate
cancer during radiation therapy. Acta Oncol. 49:1269–1275. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Z, Mayr NA, Gao M, et al: Onset time
of tumor repopulation for cervical cancer: first evidence from
clinical data. Int J Radiat Oncol Biol Phys. 84:478–484. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang JZ and Li XA: Impact of tumor
repopulation on radiotherapy planning. Int J Radiat Oncol Biol
Phys. 61:220–227. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Petersen C, Zips D, Krause M, et al:
Repopulation of FaDu human squamous cell carcinoma during
fractionated radiotherapy correlates with reoxygenation. Int J
Radiat Oncol Biol Phys. 51:483–493. 2001. View Article : Google Scholar
|
|
16
|
Rofstad EK: Repopulation between radiation
fractions in human melanoma xenografts. Int J Radiat Oncol Biol
Phys. 23:63–68. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allam A, Perez LA, Huang P, et al: The
effect of the overall treatment time of fractionated irradiation on
the tumor control probability of a human soft tissue sarcoma
xenograft in nude mice. Int J Radiat Oncol Biol Phys. 32:105–111.
1995. View Article : Google Scholar
|
|
18
|
Milas L, Yamada S, Hunter N, Guttenberger
R and Thames HD: Changes in TCD50 as a measure of clonogen doubling
time in irradiated and unirradiated tumors. Int J Radiat Oncol Biol
Phys. 21:1195–1202. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Petersen C, Eicheler W, Frömmel A, et al:
Proliferation and micromilieu during fractionated irradiation of
human FaDu squamous cell carcinoma in nude mice. Int J Radiat Biol.
79:469–477. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramsay J, Suit HD, Preffer FI and Sedlacek
R: Changes in bromodeoxyuridine labeling index during radiation
treatment of an experimental tumor. Radiat Res. 116:453–461. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thames HD, Ruifrok AC, Milas L, et al:
Accelerated repopulation during fractionated irradiation of a
murine ovarian carcinoma: downregulation of apoptosis as a possible
mechanism. Int J Radiat Oncol Biol Phys. 35:951–962. 1996.
View Article : Google Scholar
|
|
22
|
Kovarík J, Skry GD, Mikel J and Svoboda
VH: Changes of Ki67 index of various tumors during radiation
therapy. Neoplasma. 43:89–92. 1996.PubMed/NCBI
|
|
23
|
Gasinska A, Richter P, Darasz Z, et al:
Gender-related differences in repopulation and early tumor response
to preoperative radiotherapy in rectal cancer patients. J
Gastrointest Surg. 15:1568–1576. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Durand RE: Tumor repopulation during
radiotherapy: quantitation in two xenografted human tumors. Int J
Radiat Oncol Biol Phys. 39:803–808. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kummermehr JC: Tumour stem cells - the
evidence and the ambiguity. Acta Oncol. 40:981–988. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gerlinger M, Rowan AJ, Horswell S, et al:
Intratumor heterogeneity and branched evolution revealed by
multiregion sequencing. N Engl J Med. 366:883–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gilbertson RJ and Graham TA: Cancer:
Resolving the stem-cell debate. Nature. 488:462–463. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen J, Li Y, Yu TS, McKay RM, et al: A
restricted cell population propagates glioblastoma growth after
chemotherapy. Nature. 488:522–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schepers AG, Snippert HJ, Stange DE, et
al: Lineage tracing reveals Lgr5+ stem cell activity in mouse
intestinal adenomas. Science. 337:730–735. 2012.
|
|
30
|
Moncharmont C, Levy A, Gilormini M, et al:
Targeting a cornerstone of radiation resistance: cancer stem cell.
Cancer Lett. 322:139–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Furth J, Kahn MC and Breedis C: The
transmission of leukemia in mice with a single cell. Am J Cancer.
31:276–282. 1937.
|
|
32
|
Hewitt HB: Studies of the dissemination
and quantitative transplantation of a lymphocytic leukaemia of CBA
mice. Br J Cancer. 12:378–401. 1958. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leyton JV, Olafsen T, Lepin EJ, et al:
Humanized radioiodinated minibody for imaging of prostate stem cell
antigen-expressing tumors. Clin Cancer Res. 14:7488–7496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshii Y, Furukawa T, Kiyono Y, et al:
Internal radiotherapy with copper-64-diacetyl-bis
(N4-methylthiosemicarbazone) reduces CD133+ highly
tumorigenic cells and metastatic ability of mouse colon carcinoma.
Nucl Med Biol. 38:151–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tsurumi C, Esser N, Firat E, et al:
Non-invasive in vivo imaging of tumor-associated CD133/prominin.
PLoS One. 5:e156052010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vlashi E, Kim K, Lagadec C, et al: In vivo
imaging, tracking, and targeting of cancer stem cells. J Natl
Cancer Inst. 101:350–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van WA and Elsinga PH: Proliferation
markers for the differential diagnosis of tumor and inflammation.
Curr Pharm Des. 14:3326–3339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bading JR and Shields AF: Imaging of cell
proliferation: status and prospects. J Nucl Med. 49(Suppl 2):
64S–80S. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soloviev D, Lewis D, Honess D and Aboagye
E: [(18)F]FLT: an imaging biomarker of tumour proliferation for
assessment of tumour response to treatment. Eur J Cancer.
48:416–424. 2012.
|
|
41
|
Leyton J, Latigo JR, Perumal M, Dhaliwal
H, He Q and Aboagye EO: Early detection of tumor response to
chemotherapy by 3′-deoxy-3′-[18F]fluorothymidine positron emission
tomography: the effect of cisplatin on a fibrosarcoma tumor model
in vivo. Cancer Res. 65:4202–4210. 2005.
|
|
42
|
Yamamoto Y, Nishiyama Y, Ishikawa S, et
al: Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67
immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med
Mol Imaging. 34:1610–1616. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yamamoto Y, Ono Y, Aga F, Kawai N, Kudomi
N and Nishiyama Y: Correlation of 18F-FLT uptake with tumor grade
and Ki-67 immunohistochemistry in patients with newly diagnosed and
recurrent gliomas. J Nucl Med. 53:1911–1915. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vesselle H, Grierson J, Muzi M, et al: In
vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT)
as a proliferation imaging tracer in humans: correlation of
[(18)F]FLT uptake by positron emission tomography with Ki-67
immunohistochemistry and flow cytometry in human lung tumors. Clin
Cancer Res. 8:3315–3323. 2002.
|
|
45
|
van Westreenen HL, Cobben DC, Jager PL, et
al: Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
J Nucl Med. 46:400–404. 2005.
|
|
46
|
Benz MR, Czernin J, Allen-Auerbach MS, et
al: 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
for response assessment in soft tissue sarcoma: a pilot study to
correlate imaging findings with tissue thymidine kinase 1 and Ki-67
activity and histopathologic response. Cancer. 118:3135–3144.
2012.
|
|
47
|
Yamamoto Y, Kameyama R, Izuishi K, et al:
Detection of colorectal cancer using 18F-FLT PET: comparison with
18F-FDG PET. Nucl Med Commun. 30:841–845. 2009. View Article : Google Scholar
|
|
48
|
Kameyama R, Yamamoto Y, Izuishi K, et al:
Detection of gastric cancer using 18F-FLT PET: comparison with
18F-FDG PET. Eur J Nucl Med Mol Imaging. 36:382–388. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schwartz JL, Tamura Y, Jordan R, Grierson
JR and Krohn KA: Monitoring tumor cell proliferation by targeting
DNA synthetic processes with thymidine and thymidine analogs. J
Nucl Med. 44:2027–2032. 2003.PubMed/NCBI
|
|
50
|
Chalkidou A, Landau DB, Odell EW,
Cornelius VR, O’Doherty MJ and Marsden PK: Correlation between
Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in
patients with cancer: A systematic review and meta-analysis. Eur J
Cancer. 48:3499–3513. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hoshikawa H, Kishino T, Mori T, Nishiyama
Y, Yamamoto Y and Mori N: The value of 18F-FLT PET for detecting
second primary cancers and distant metastases in head and neck
cancer patients. Clin Nucl Med. 38:e318–e323. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Herrmann K, Erkan M, Dobritz M, et al:
Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission
tomography (FLT PET) and FDG PET/CT for the detection and
characterization of pancreatic tumours. Eur J Nucl Med Mol Imaging.
39:846–851. 2012.
|
|
53
|
Han D, Yu J, Zhong X, et al: Comparison of
the diagnostic value of 3-deoxy-3-18F-fluorothymidine and
18F-fluorodeoxyglucose positron emission tomography/computed
tomography in the assessment of regional lymph node in thoracic
esophageal squamous cell carcinoma: a pilot study. Dis Esophagus.
25:416–426. 2012. View Article : Google Scholar
|
|
54
|
van Waarde A, Cobben DC, Suurmeijer AJ, et
al: Selectivity of 18F-FLT and 18F-FDG for differentiating tumor
from inflammation in a rodent model. J Nucl Med. 45:695–700.
2004.PubMed/NCBI
|
|
55
|
Halter G, Buck AK, Schirrmeister H, et al:
[18F] 3-deoxy-3′-fluorothymidine positron emission tomography:
alternative or diagnostic adjunct to
2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in
the workup of suspicious central focal lesions? J Thorac Cardiovasc
Surg. 127:1093–1099. 2004.
|
|
56
|
Agool A, Slart RH, Thorp KK, et al: Effect
of radiotherapy and chemotherapy on bone marrow activity: a
18F-FLT-PET study. Nucl Med Commun. 32:17–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Troost EG, Bussink J, Hoffmann AL, Boerman
OC, Oyen WJ and Kaanders JH: 18F-FLT PET/CT for early response
monitoring and dose escalation in oropharyngeal tumors. J Nucl Med.
51:866–874. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Scheffler M, Kobe C, Zander T, et al:
Monitoring reversible and irreversible EGFR inhibition with
erlotinib and afatinib in a patient with EGFR-mutated non-small
cell lung cancer (NSCLC) using sequential [18F]fluorothymidine
(FLT-)PET. Lung Cancer. 77:617–620. 2012.PubMed/NCBI
|
|
59
|
Yue J, Chen L, Cabrera AR, et al:
Measuring tumor cell proliferation with 18F-FLT PET during
radiotherapy esophageal squamous cell carcinoma: a pilot clinical
study. J Nucl Med. 51:528–534. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fowler JF: Rapid repopulation in
radiotherapy: a debate on mechanism. The phantom of tumor treatment
- continually rapid proliferation unmasked. Radiother Oncol.
22:156–158. 1991. View Article : Google Scholar
|
|
61
|
Schmidt-Ullrich RK, Contessa JN, Dent P,
et al: Molecular mechanisms of radiation-induced accelerated
repopulation. Radiat Oncol Investig. 7:321–330. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Everitt S, Hicks RJ, Ball D, et al:
Imaging cellular proliferation during chemo-radiotherapy: a pilot
study of serial 18F-FLT positron emission tomography/computed
tomography imaging for non-small-cell lung cancer. Int J Radiat
Oncol Biol Phys. 75:1098–1104. 2009. View Article : Google Scholar
|
|
63
|
Fatema CN, Zhao S, Zhao Y, et al:
Monitoring tumor proliferative response to radiotherapy using
(18)F-fluorothymidine in human head and neck cancer xenograft in
comparison with Ki-67. Ann Nucl Med. 27:355–362. 2013. View Article : Google Scholar : PubMed/NCBI
|
